C71T
CANCELLED SECTION 71
07/17/2026
Back to search
Official data from USPTO
PANDEMIC RESPONSE SOLUTIONS PARTNERS IN PROTECTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079244657Class
1, 5, 35, 42, 44
Filing
79244657
Registration
5946687
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
08/11/2026
Trademark type
Combined
Nice classes
1, 5, 35, 42, 44
Filing date
06/01/2018
Registration date
12/31/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/17/2026
Last transaction
08/11/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Berkshire, GB
Examiner
FARRELL, ANNE M
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the following: a stylized design of a globe with lines divided into four sections in the colors red, gray, blue and turquoise. The stylized wording "PANDEMIC RESPONSE SOLUTIONS" in gray appears to the right of the globe design. There is a gray horizontal line below that wording and the globe design. Below the line is the stylized wording "PARTNERS IN PROTECTION" in gray. The enclosed white in the mark represents background and is not claimed as a feature of the mark.
Holders and representatives
Holders
Seqirus UK Limited
Representatives
Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical and biological reagents for scientific and non-medical purposes; cell cultures and cell culture media for laboratoryscientific and research use; chemical preparations for scientific and industrial purposes
Class 5
Pharmaceutical preparationsvaccines and antivirals; adjuvants for medical purposes; antigens for medical purposes
Class 35
Providing business consulting and information services in relation to crisis management and pandemic preparedness; providing business information on pandemic preparedness via a website
Class 42
Medical research services; scientific research for medical purposes; scientific investigations for medical purposes; design and development of medical technology
Class 44
Medical services; medical information services concerning vaccines; providing medical information in the healthcare sector; providing medical information and consulting services in relation to crisis management and pandemic preparedness; providing medical information on pandemic preparedness via a website
Publications
History of USPTO decisions and trademark events.
39 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/03/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/31/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/05/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/14/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/20/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
05/20/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/31/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2019
PUBO
PUBLISHED FOR OPPOSITION
10/15/2019
GPNX
NOTIFICATION PROCESSED BY IB
10/12/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/25/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/25/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/09/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
09/06/2019
ALIE
ASSIGNED TO LIE
09/06/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/06/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
09/06/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/30/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/30/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/30/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/05/2019
GNFR
FINAL REFUSAL E-MAILED
03/05/2019
CNFR
FINAL REFUSAL WRITTEN
03/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2019
RFNT
REFUSAL PROCESSED BY IB
12/21/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/01/2018
RFRR
REFUSAL PROCESSED BY MPU
11/30/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/16/2018
CNRT
NON-FINAL ACTION WRITTEN
11/15/2018
MAFR
APPLICATION FILING RECEIPT MAILED
11/13/2018
DOCK
ASSIGNED TO EXAMINER
11/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/01/2018
Continuous trademark protection
Get notified about every new filing that threatens PANDEMIC RESPONSE SOLUTIONS PARTNERS IN PROTECTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.